About the Conference

The Trans-Pacific Health Sciences Dialogue is a meeting for C-level biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.

This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.

Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!

Day 1 PhotosDay 2 Photos

In 2015, the Trans-Pacific Health Sciences Dialogue will be held at:

Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115

Boston_small

Sponsors

Sponsors_200px

Supporters

Supporters_200px

Who Should Attend

WhoShouldAttend

The Trans-Pacific Health Sciences Dialogue is an event for senior biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.

Industry News from FiercePharmaAsia

Read more

Industry News from PharmAsia

  • More Companies Tapping Direct Sales Route In ChinaUnder the influence of a changing policy environment, China's healthcare companies are experiencing a development bottleneck. The need to upgrade to new business models and finding new ways of doing so have become realities for many companies, and more and more are tapping into the opportunities presented by direct sales, including A-share market-listed and state-owned companies.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/v__BUM5ATWs" height="1" width="1" alt="" />
Read more